BioCatalystWatch
IMMPWorkspace / IMMP / OverviewCompany library
Price
Market cap
Next catalystDec 14, 2026Eftilagimod alfa + pembrolizumab — TACTI-003, including CPS <1 Cohort B · Phase 2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Eftilagimod alfa + pembrolizumab — TACTI-003, including CPS <1 Cohort B

MHC Class II

PreINDP1P2P3FilingApproved
Upcoming / outlook

IMP761

LAG-3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Eftilagimod alfa + pembrolizumab — TACTI-003, including CPS <1 Cohort B

MHC Class II

PreINDP1P2P3FilingApproved
Upcoming / outlook

IMP761

LAG-3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

eftilagimod alpha (efti; IMP321)

MHC Class II

eftilagimod alpha (efti; IMP321)

MHC Class II

PreINDP1P2P3FilingApproved
eftilagimod alpha (efti; IMP321)

MHC Class II

PreINDP1P2P3FilingApproved
IMP701 (LAG525; ieramilimab)

LAG-3

PreINDP1P2P3FilingApproved
IMP761

LAG-3

eftilagimod alpha (efti; IMP321)

MHC Class II

eftilagimod alpha (efti; IMP321)

MHC Class II

PreINDP1P2P3FilingApproved
eftilagimod alpha (efti; IMP321)

MHC Class II

PreINDP1P2P3FilingApproved

History / paused

eftilagimod alpha (efti; IMP321)

MHC Class II

PreINDP1P2P3FilingApproved
IMP731 (GSK2831781/GSK'781)

LAG-3

PreINDP1P2P3FilingApproved

Financial position

Cash and cash equivalents

Source and basis

Short-term investments

Source and basis

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

IMMP SEC archive